Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 9/20 | 0.35 |
| ▸ | ROCK2 | O75116 | 5/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.32 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5811064 | 0.86 | EGLN1 (0.35) | EGLN1ROCK2CXCR4 | |
| SCHEMBL5164622 | 0.86 | ROCK2 (0.37) | ROCK2CXCR4 | |
| SCHEMBL1738621 | 0.85 | ROCK2 (0.39) | ROCK2SIGMAR1LMNA | |
| SCHEMBL1737818 | 0.85 | ROCK2 (0.39) | ROCK2SIGMAR1LMNA | |
| SCHEMBL1737234 | 0.85 | ROCK2 (0.39) | ROCK2SIGMAR1LMNA | |
| SCHEMBL1738393 | 0.84 | ROCK2 (0.39) | ROCK2SIGMAR1LMNA | |
| SCHEMBL1737745 | 0.84 | ROCK2 (0.39) | ROCK2SIGMAR1LMNA | |
| SCHEMBL1737744 | 0.84 | ROCK2 (0.39) | ROCK2SIGMAR1LMNA | |
| SCHEMBL5808251 | 0.84 | EGLN1 (0.36) | EGLN1ROCK2CXCR4 | |
| SCHEMBL1738835 | 0.83 | ROCK2 (0.39) | ROCK2SIGMAR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006106416-A1 | PYRIDIL-LACTAMS AND THEIR USE 5 -HTl RECEPTORS LIGAN | PFIZER PRODUCTS INC. (US) | 2006-10-12 | — | — | WO | claimed |
| WO-2006106416-A1 | PYRIDIL-LACTAMS AND THEIR USE 5 -HTl RECEPTORS LIGAN | PFIZER PRODUCTS INC. (US) | 2006-10-12 | — | — | WO | disclosed |